A study released on autism spectrum disorder (ASD) in the January issue of JAMA Psychiatry sheds new light on old knowledge – that individuals with ASD have a higher rate of co-occurring disorders than the general population.
However, the study raises the bar in two ways: 1) it draws on an unmatched amount of data – nearly 6 million people; and 2) provides greater insight into the association between pairs of conditions over time.
The 2019 National Council for Behavioral Health Conference that occurred in Nashville last week provides reason to pause. Its theme, “Celebrating 50 Years of WE”, gets to the very heart of what will bring about change – for behavioral health and beyond. Together, we can make a difference.
The United States is in the midst of an unprecedented opioid epidemic, but the unfortunate reality is that only one out of 10 Americans with a substance use disorder (SUD) receives treatment.
That statistic alone is shocking, but even worse, widespread adoption of evidence-based practices has been limited.
With one in five Americans suffering from a mental illness at any point in their lives, the demand for behavioral health services is loud and clear, but the reality is that many people do not have access to quality care.
Indeed, only 26 percent of the need for mental health services is met in this country, according to the U.S. Department of Health & Human Services.
As a mental health professional, two experiences with suicide have stayed with me over time.
The first occurred while working on an inpatient unit. A young woman jumped five stories from a parking garage and survived.
Are people with serious mental illness more prone to violence than the general population? In the aftermath of almost weekly mass shootings and other acts of extreme violence, this question inevitably emerges.
In 1949, Mental Health America led the way in establishing May as Mental Health Awareness Month. Since that time, mental health care has come a long way through a better understanding of behavioral health conditions, the development of corresponding evidence-based practices, and improved health care delivery.
However, we still have a ways to go.
The oft-cited statistic that one out of every 68 children in America has autism spectrum disorder (ASD) serves as the ongoing reminder that ASD affects many families, school systems and communities.
The challenge for the health care system at large is to determine the best treatment at a cost society can bear.
The opioid epidemic has become an all-too-familiar topic in hospital grand rounds, in political speeches, in daily news briefings, and in social media hashtags.
However, there is another epidemic, one that in many cases actually overlaps with, and exacerbates, the opioid crisis: benzodiazepine misuse.